Literature DB >> 1935300

Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome.

E R Pacht1, A P Timerman, M G Lykens, A J Merola.   

Abstract

The adult respiratory distress syndrome (ARDS) is a devastating clinical illness characterized by refractory hypoxemia and high-permeability pulmonary edema. Reactive oxygen species such as hydrogen peroxide and hypochlorous acid may play a key role in the pathogenesis of the acute lung injury. Glutathione (GSH) is a tripeptide that is able to react with and effectively neutralize oxidants such as hydrogen peroxide and hypochlorous acid. The present study found that the alveolar epithelial lining fluid of patients with ARDS was deficient in total GSH compared to normal subjects (21.7 mumols +/- 7.8 mumols vs 91.8 mumols +/- 14.5 mumols; p = 0.002). In addition, if GSH was measured in unconcentrated bronchoalveolar lavage (BAL) fluid and indexed to total BAL protein, there was also a deficiency in patients with ARDS compared to normal subjects (0.004 +/- 0.003 nmol of GSH per microgram of total protein vs 0.026 +/- 0.005 nmol of GSH per microgram of total protein; p = 0.002). Since patients with ARDS are subjected to an increased burden of oxidants in the alveolar fluid, principally released by recruited neutrophils, this deficiency of GSH may predispose these patients to enhanced lung cell injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1935300     DOI: 10.1378/chest.100.5.1397

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  53 in total

Review 1.  The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.

Authors:  J Cranshaw; M J D Griffiths; T W Evans
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 2.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

3.  Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2.

Authors:  Heather M Brechbuhl; Neal Gould; Remy Kachadourian; Wayne R Riekhof; Dennis R Voelker; Brian J Day
Journal:  J Biol Chem       Date:  2010-03-23       Impact factor: 5.157

4.  Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases.

Authors:  I L Chapple
Journal:  Clin Mol Pathol       Date:  1996-10

Review 5.  Is sepsis a mediator-inhibitor mismatch?

Authors:  M Lamy; G Deby-Dupont
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

6.  Temporal changes in whole-blood and plasma glutathione in ICU patients with multiple organ failure.

Authors:  U B Fläring; O E Rooyackers; C Hebert; T Bratel; F Hammarqvist; J Wernerman
Journal:  Intensive Care Med       Date:  2005-07-06       Impact factor: 17.440

7.  Oxidation of plasma cysteine/cystine redox state in endotoxin-induced lung injury.

Authors:  Smita S Iyer; Dean P Jones; Kenneth L Brigham; Mauricio Rojas
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-29       Impact factor: 6.914

8.  Alcohol screening scores and 90-day outcomes in patients with acute lung injury.

Authors:  Brendan J Clark; André Williams; Laura M Cecere Feemster; Katharine A Bradley; Madison Macht; Marc Moss; Ellen L Burnham
Journal:  Crit Care Med       Date:  2013-06       Impact factor: 7.598

9.  99MTc-Hexamethylpropyleneamine Oxime Imaging for Early Detection of Acute Lung Injury in Rats Exposed to Hyperoxia or Lipopolysaccharide Treatment.

Authors:  Said H Audi; Anne V Clough; Steven T Haworth; Meetha Medhora; Mahsa Ranji; John C Densmore; Elizabeth R Jacobs
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

Review 10.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.